Prescient Therapeutics Ltd - Asset Resilience Ratio

Latest as of December 2025: 52.86%

Prescient Therapeutics Ltd (PTX) has an Asset Resilience Ratio of 52.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Prescient Therapeutics Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$9.77 Million

≈ $6.91 Million USD Cash + Short-term Investments

Total Assets

AU$18.48 Million

≈ $13.08 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Prescient Therapeutics Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Prescient Therapeutics Ltd assets under control.

Liquid Assets Composition Over Time

This chart breaks down Prescient Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Prescient Therapeutics Ltd carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$9.75 Million	52.74%
Short-term Investments	AU$20.97K	0.11%
Total Liquid Assets	AU$9.77 Million	52.86%

Asset Resilience Insights

Very High Liquidity: Prescient Therapeutics Ltd maintains exceptional liquid asset reserves at 52.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Prescient Therapeutics Ltd Industry Peers by Asset Resilience Ratio

Compare Prescient Therapeutics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Prescient Therapeutics Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Prescient Therapeutics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	0.14%	AU$20.00K ≈ $14.15K	AU$14.56 Million ≈ $10.30 Million	-49.00pp
2024-06-30	49.13%	AU$10.02 Million ≈ $7.09 Million	AU$20.39 Million ≈ $14.43 Million	-22.09pp
2023-06-30	71.22%	AU$20.02 Million ≈ $14.17 Million	AU$28.11 Million ≈ $19.89 Million	+71.11pp
2022-06-30	0.11%	AU$20.00K ≈ $14.15K	AU$17.62 Million ≈ $12.47 Million	+0.02pp
2021-06-30	0.10%	AU$20.00K ≈ $14.15K	AU$20.97 Million ≈ $14.84 Million	-0.07pp
2020-06-30	0.17%	AU$20.00K ≈ $14.15K	AU$12.07 Million ≈ $8.54 Million	-64.20pp
2019-06-30	64.37%	AU$9.66 Million ≈ $6.83 Million	AU$15.01 Million ≈ $10.62 Million	+9.26pp
2018-06-30	55.11%	AU$5.51 Million ≈ $3.90 Million	AU$9.99 Million ≈ $7.07 Million	-7.57pp
2017-06-30	62.68%	AU$7.67 Million ≈ $5.42 Million	AU$12.23 Million ≈ $8.65 Million	+1.71pp
2005-06-30	60.96%	AU$2.55 Million ≈ $1.80 Million	AU$4.18 Million ≈ $2.96 Million	-27.03pp
2004-06-30	87.99%	AU$3.65 Million ≈ $2.58 Million	AU$4.15 Million ≈ $2.94 Million	+20.66pp
2003-06-30	67.34%	AU$1.10 Million ≈ $778.32K	AU$1.63 Million ≈ $1.16 Million	-14.68pp
2002-06-30	82.02%	AU$1.56 Million ≈ $1.11 Million	AU$1.90 Million ≈ $1.35 Million	-8.15pp
2001-06-30	90.16%	AU$3.86 Million ≈ $2.73 Million	AU$4.28 Million ≈ $3.03 Million	--

pp = percentage points

About Prescient Therapeutics Ltd

AU:PTX Australia Biotechnology

Market Cap

$50.59 Million

AU$71.50 Million AUD

Market Cap Rank

#21948 Global

#771 in Australia

Share Price

AU$0.07

Change (1 day)

+0.00%

52-Week Range

AU$0.04 - AU$0.11

All Time High

AU$0.30